BIOCRYST PHARMACEUTICA
7.5000
27-十一月-24 15:45:00
15 分钟延时
股票
+0.0100
+0.13%
今日范围
7.4250 - 7.6300
ISIN
N/A
来源
NASDAQ
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 9月 2022 06:00:52 条件 Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conferences
31 8月 2022 15:01:59 条件 Nasdaq GlobeNewswire
-
31 8月 2022 06:00:00 条件 Nasdaq GlobeNewswire
-
26 8月 2022 06:00:00 条件 Nasdaq GlobeNewswire
-
25 8月 2022 06:00:14 条件 Nasdaq GlobeNewswire
-
BioCryst Announces Approval of ORLADEYO® (berotralstat) in Saudi Arabia
18 8月 2022 06:00:00 条件 Nasdaq GlobeNewswire
-
BioCryst Reports Second Quarter 2022 Financial Results and Upcoming Key Milestones
04 8月 2022 06:00:24 条件 Nasdaq GlobeNewswire
-
BioCryst Resumes Enrollment in BCX9930 Clinical Program
04 8月 2022 05:58:25 条件 Nasdaq GlobeNewswire
-
BioCryst to Report Second Quarter 2022 Financial Results on August 4
21 7月 2022 06:00:44 条件 Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conference
15 7月 2022 06:00:23 条件 Nasdaq GlobeNewswire
-
01 7月 2022 06:00:00 条件 Nasdaq GlobeNewswire
-
22 6月 2022 06:00:02 条件 Nasdaq GlobeNewswire
-
BioCryst Selects Pint Pharma as Commercial Partner for ORLADEYO® (berotralstat) in Latin America
09 6月 2022 06:00:00 条件 Nasdaq GlobeNewswire
-
FDA Grants Fast Track Designation for BioCryst’s ALK-2 Inhibitor, BCX9250
08 6月 2022 06:00:01 条件 Nasdaq GlobeNewswire
-
BioCryst Announces Approval of ORLADEYO® (berotralstat) by Swissmedic
07 6月 2022 08:00:02 条件 Nasdaq GlobeNewswire
-
06 6月 2022 06:00:30 条件 Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conferences
01 6月 2022 06:00:15 条件 Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conferences
06 5月 2022 06:00:28 条件 Nasdaq GlobeNewswire
-
BioCryst Reports First Quarter 2022 Financial Results and Upcoming Key Milestones
05 5月 2022 06:00:11 条件 Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 5月 2022 15:15:39 条件 Nasdaq GlobeNewswire